ArsenalBio

South San Francisco, CA · Founded 2018 · Privately Held (backing)

Operator of a programmable cell therapy company intended to discover, develop, and commercialize curative immune cell therapies. ArsenalBio is based in South San Francisco, CA and was founded in 2018. Its last known valuation is $1.9 billion. It has raised $631 million.

Last price · $/share
—
Implied valuation
$1.9B
Total raised
$630.8M
Last round
—

Who backs ArsenalBio?

24 investors
InvestorType
SoftBank Investment AdvisersGrowth equity
Kleiner PerkinsOther
University of CaliforniaOther
ARCH Venture PartnersVenture capital
Emerson CollectiveOther
NVentures (Santa Clara)Venture capital
Hitachi VenturesVenture capital
Osage University PartnersVenture capital
Sixth Street PartnersGrowth equity
Bristol-Myers Squibb—
+ 14 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

ArsenalBio investors

24 investors are on record for ArsenalBio, including SoftBank Investment Advisers, Kleiner Perkins, University of California and ARCH Venture Partners. By type, the record holds 4 venture capital firms and 2 family offices.

Free account
More of ArsenalBio with a free account
  • ·The complete investor list: 24 names
  • ·Watch ArsenalBio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 24 firms already write checks for companies like ArsenalBio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View